Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib (2X-121)—a differentiated, dual PARP and ...

M acquisition structured with majority seller financing tied to performance; company expects to complete transaction without shareholder dilution NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- 1847 ...

Webull (NASDAQ:BULL) executives highlighted record revenue, rising customer assets, and continued adjusted profitability in ...

M acquisition structured with majority seller financing tied to performance; company expects to complete transaction without shareholder dilution NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- 1847 Hold ...

Financing Expected to Fund Completion of Phase 2 Ovarian Cancer TrialFinancing Supports Acceleration Toward Pivotal Trial and CommercializationFinancing Structured ...

An affidavit of loss declares the loss or destruction of a security certificate, including details for its replacement. Learn about its purpose and applications.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at ...

Company marks first full year as public company with record revenue of $571 million and record net deposits of $8.6 billion, representing a 46% and 91% ...

J.C. Flowers & Co. LLC ("J.C. Flowers"), a leading private investment firm dedicated to investing globally in the financial services industry, today announced an equity commitment of up to $200 ...